课题基金 / 基金详情

Regulatory T cells in allogeneic transplantation

Regulatory T cells in allogeneic transplantation
同种异体移植中的调节性T细胞
批准号:
8534275
负责人:
Robert S Negrin
金额:
$49.7万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2017-05-31

项目摘要

项目成果

Robert S Negrin的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):免疫调节对健康和疾病至关重要。同种异体造血细胞移植后,免疫反应失调导致移植物抗宿主病(GVHD),有效的免疫识别导致控制潜在疾病,称为移植物抗肿瘤效应,这一点再清楚不过了。在本提案中,我们将研究免疫反应的关键调节因子,即CD4+CD25+CD127loFoxP3+调节性T细胞(Treg),这些细胞已被证明在小鼠模型中对GVHD的控制有深远的影响,但允许GVT反应。由于抑制了有害的同种免疫效应(也可能影响免疫组织),以规定剂量使用Treg以及常规CD4和CD8细胞(Tcon)也导致更有效的免疫恢复。此外,许多研究表明,Treg也可用于治疗慢性GVHD。因此,本提案的目的是直接翻译临床前动物研究中发展的生物学概念,以验证高纯度Treg的过继转移将导致GVHD控制,但促进加速免疫重建,以及治疗慢性GVHD的假设。该提案涉及两项临床试验,均使用通过IRB和IND批准的临床方案通过高速细胞分选分离的高纯化Treg群体。这些研究将直接将重要的生物学概念从实验室转化为临床。如果取得成功,这些研究将对异体造血细胞移植领域产生重大影响,并可能为自身免疫性疾病的新治疗和诱导实体器官移植耐受奠定基础。
英文摘要
DESCRIPTION (provided by applicant): Immune regulation is critical in health and disease. Nowhere is this clearer than following allogeneic hematopoietic cell transplantation where dysregulated immune responses result in graft-versus-host disease (GVHD) and effective immune recognition results in control of the underlying disease, termed graft-versus- tumor effects. In this proposal, we will study the key regulators of immune reactions, namely CD4+CD25+CD127loFoxP3+ regulatory T cells (Treg) which have been demonstrated to have profound effects on control of GVHD in murine models, yet allow for GVT responses. Due to the suppression of the deleterious alloimmune effects which can also impact immune tissues, the use of Treg at defined doses along with conventional CD4 and CD8 cells (Tcon) has also resulted in more effective immune recovery. Further, it has been suggested by a number of studies that Treg can also be used to treat chronic GVHD. Therefore, the aims of this proposal are to directly translate the biological concepts developed in preclinical animal studies to test te hypothesis that the adoptive transfer of highly purified Treg will result in control of GVHD, yet promote accelerated immune reconstitution, as well as treat chronic GVHD. The Proposal involves two clinical trials both utilizing highly purified populations of Treg isolated by high-sped cell sorting through IRB and IND approved clinical protocols. The studies will directly translate important biological concepts from the laboratory to the clinic. If successful the studies could have a major impact on the field of allogeneic hematopoietic cell transplantation and could also set the stage for new treatments of autoimmune disorders and induction of solid organ transplantation tolerance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulatory T cells in allogeneic transplantation
  • 批准号:
    9065603
  • 项目类别:
  • 资助金额:
    $52.2万
  • 财政年份:
    2012
  • 负责人:
    Robert S Negrin
  • 依托单位:
Regulatory T cells in allogeneic transplantation
  • 批准号:
    8903997
  • 项目类别:
  • 资助金额:
    $51.42万
  • 财政年份:
    2012
  • 负责人:
    Robert S Negrin
  • 依托单位:
Regulatory T cells in allogeneic transplantation
  • 批准号:
    8701379
  • 项目类别:
  • 资助金额:
    $51.16万
  • 财政年份:
    2012
  • 负责人:
    Robert S Negrin
  • 依托单位:
Regulatory T cells in allogeneic transplantation
  • 批准号:
    8343992
  • 项目类别:
  • 资助金额:
    $52.02万
  • 财政年份:
    2012
  • 负责人:
    Robert S Negrin
  • 依托单位:
海外基金